Oppenheimer analysts upgrades an Outperform rating for PMV Pharmaceuticals Inc (PMVP)

PMV Pharmaceuticals Inc’s recent filing unveils that its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $0.9 million on Sep 10 ’25. In the deal valued at $1.80 per share,500,000 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 5,975,291 shares worth roughly $8.25 million.

Then, OrbiMed Private Investments V, bought 2,283,654 shares, generating $3,653,846 in total proceeds.

Before that, Ticktin Robert sold 23,151 shares. PMV Pharmaceuticals Inc shares valued at $24,651 were divested by the General Counsel & COO at a price of $1.06 per share. As a result of the transaction, Ticktin Robert now holds 98,695 shares, worth roughly $0.14 million.

Oppenheimer upgraded its PMV Pharmaceuticals Inc [PMVP] rating to an Outperform from a a Perform in a research note published recently. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Jefferies began covering PMVP with “Buy” recommendation on April 12, 2024. Ladenburg Thalmann started covering the stock on December 27, 2023. It rated PMVP as “a Buy”.

Price Performance Review of PMVP

On Tuesday, PMV Pharmaceuticals Inc [NASDAQ:PMVP] saw its stock jump 2.99% to $1.38. Over the last five days, the stock has gained 15.00%. PMV Pharmaceuticals Inc shares have fallen nearly -9.21% since the year began. Nevertheless, the stocks have fallen -8.61% over the past one year. While a 52-week high of $1.84 was reached on 09/10/25, a 52-week low of $0.81 was recorded on 05/16/25.

Levels Of Support And Resistance For PMVP Stock

The 24-hour chart illustrates a support level at 1.3369, which if violated will result in even more drops to 1.2939. On the upside, there is a resistance level at 1.4186. A further resistance level may holdings at 1.4573.

How much short interest is there in PMV Pharmaceuticals Inc?

A steep rise in short interest was recorded in PMV Pharmaceuticals Inc stocks on 2025-08-29, dropping by 13978.0 shares to a total of 0.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.82 million shares. There was a decline of -1.73%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.